Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals, Inc. | Executive Vice Chair, Director | $6.63 M | -$1.29 M | -16.3% | Feb 9, 2024 |
ALKS, ALKSV | Alkermes plc. | Director | $537 K | May 31, 2024 | ||
AQST | Aquestive Therapeutics, Inc. | Director | Jun 15, 2021 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|